INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$23.64
Tradestie Score
67
Market Cap
$1.15B
P/E Ratio
3.6
Revenue Growth
0.1%
Analyst Upside
+50.2%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$6.03
|
$1.78B | - | 58 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.33
|
$1.78B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.32
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$33.78
|
$1.68B | - | 58 | Compare |
|
MNKD
Mannkind Corporation
|
$3.84
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$42.30
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.96
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$41.69
|
$1.56B | 94.1 | 58 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$90.80
|
$1.55B | - | 61 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$34.45
|
$1.55B | 13.5 | 63 | Compare |
More INVA Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry